Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony M Barsotti

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cell|August 10, 2010
Noncoding RNAs: the missing "linc" in p53-mediated repressionAnthony M Barsotti, Carol Prives
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2008
A role for caspase 2 and PIDD in the process of p53-mediated apoptosisNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
Epigenomics|August 29, 2015
Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutationsAnthony M Barsotti, Michael Ryskin, Robert A Rollins
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent mannerNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
The Journal of Biological Chemistry|November 24, 2011
p53-Dependent induction of PVT1 and miR-1204Anthony M Barsotti, Rachel Beckerman, Oleg Laptenko, et al.
Journal of Medicinal Chemistry|April 14, 2020
Discovery and Optimization of Glucose Uptake InhibitorsKevin G Liu, Ji-In Kim, Kellen Olszewski, et al.
Oncotarget|February 12, 2015
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growthAnthony M Barsotti, Michael Ryskin, Wenyan Zhong, et al.
Molecular Cell|October 30, 2012
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genesStephan Singer, Ruiying Zhao, Anthony M Barsotti, et al.
The EMBO Journal|May 17, 2015
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2Stephen G Dann, Michael Ryskin, Anthony M Barsotti, et al.
Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell|August 10, 2010
Noncoding RNAs: the missing "linc" in p53-mediated repressionAnthony M Barsotti, Carol Prives
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2008
A role for caspase 2 and PIDD in the process of p53-mediated apoptosisNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
Epigenomics|August 29, 2015
Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutationsAnthony M Barsotti, Michael Ryskin, Robert A Rollins
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Caspase 2 is both required for p53-mediated apoptosis and downregulated by p53 in a p21-dependent mannerNicole Baptiste-Okoh, Anthony M Barsotti, Carol Prives
The Journal of Biological Chemistry|November 24, 2011
p53-Dependent induction of PVT1 and miR-1204Anthony M Barsotti, Rachel Beckerman, Oleg Laptenko, et al.
Journal of Medicinal Chemistry|April 14, 2020
Discovery and Optimization of Glucose Uptake InhibitorsKevin G Liu, Ji-In Kim, Kellen Olszewski, et al.
Oncotarget|February 12, 2015
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growthAnthony M Barsotti, Michael Ryskin, Wenyan Zhong, et al.
Molecular Cell|October 30, 2012
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genesStephan Singer, Ruiying Zhao, Anthony M Barsotti, et al.
The EMBO Journal|May 17, 2015
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2Stephen G Dann, Michael Ryskin, Anthony M Barsotti, et al.
Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.
Pageof 2